Galt Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GALT PHARMS, and what generic alternatives to GALT PHARMS drugs are available?
GALT PHARMS has three approved drugs.
There is one US patent protecting GALT PHARMS drugs.
Drugs and US Patents for Galt Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galt Pharms | ORPHENGESIC | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 075141-001 | May 29, 1998 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Galt Pharms | ORPHENGESIC FORTE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 075141-002 | May 29, 1998 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Galt Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galt Pharms | DORAL | quazepam | TABLET;ORAL | 018708-003 | Feb 26, 1987 | 3,920,818 | ⤷ Subscribe |
Galt Pharms | DORAL | quazepam | TABLET;ORAL | 018708-001 | Dec 27, 1985 | 4,521,431 | ⤷ Subscribe |
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | 6,916,485 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.